The BRAF gene mutation plays a pivotal role in tumorigenesis, tumor development, and prognosis across various cancer types, including malignant melanoma, colon cancer, NSCLC, thyroid papillary carcinoma, and serous ovarian cancer. The gene discussed is BRAF; the disease is ovarian serous adenocarcinoma.